Previously, we observed that phenformin and 2-deoxy-D-glucose reduced tumor growth in syngeneic mice harboring the p53 gain-of-function mutation, indicating that destabilizing the oncogenic mutant p53 protein is a promising strategy in order to kill tumor cells exhibiting oncogene addiction [23]. This evidence concerns the gene TP53 and neoplasm.